 |
Category Menu |
 |
|
|
|
|
|
|
|
|
Encompasses two main industry groups. The first includes companies who manufacture health care equipment and supplies or provide health care related services, including distributors of health care products, providers of basic health care services, and owners and operators of health care facilities and organizations. The second group includes companies primarily involved in the research, development, production and marketing of pharmaceuticals and biotechnology products.
Total 6 recommendations.
|
|
|
| Ticker |
Title |
Author |
Score |
Return |
|
N/A
|
Barron`s Analyst Recommends Becton Dickson- Calls it a SAFE BET
Barrons analyst/journalist Johanna Bennett says hospital supply giant Becton Dickinson, one of the nations largest makers of surgical products such as needles, scalpels and syringes, is worth considering as it turned in double-digit profit growth for six cons...
|
|
0.0
0 votes
|
N/A
|
|
N/A
|
Stem Cell Research Plays For a Democratic Congress
Stem cell research has been a hot topic for quite a long time, but it has now become the center of attention as Democrats, who took both chambers of Congress for the first time in twelve years, have pledged to increase federal support for stem cell research....
|
|
1.0
1 votes
|
N/A
|
Buy
AMGN
|
AMGN is undervalued
* Amgen raised guidance in first 3 quarters of 2006
* Invested heavily in R&D in 2006
* Revenue growth is 31% in the past 3 years (annualized)
* EPS growth is 32% in the past 3 years (annualized)
* Key products delivered solid growth in 2006 (Avenesp, Enbr...
|
|
1.0
1 votes
|
-25.41%
|
Buy
DNA
|
Genentech is the best managed biotechnology company (Forbes List of America`s best managed companies...
In the past three years $9 billion (sales) Genentech has launched three new drugs: the $2 billion (sales) cancer treatment Avastin, Lucentis for macular degeneration ($400 million sales) and a pill, Tarceva, for lung cancer, with sales of $400 million. But the...
|
|
0.0
0 votes
|
-11.87%
|
Buy
CVD
|
Covance - pay attention to this pharmaceutical product dvelopement company.
Hungry entrepreneurialism has turned PPD into one of the largest and leanest providers of clinical trial services to the drug and biotech industries (Covance and private Quintiles are the biggest overall). Credit much of that focus to Chief Executive Fredric E...
|
|
0.0
0 votes
|
22.58%
|
Buy
DNA
|
Genentech Wowed Analysts
Genentech Inc. reported a dream fourth quarter yesterday after the market close and raised its outlook for 2007, sending shares higher by 1.15% in after hours trading. The company, which is majority owned by Swiss drug maker Roche Holding AG, saw U.S. sales to...
|
|
0.0
0 votes
|
-10.06%
|
Pages:
1
|
|
|
|
Suggestion Box
(we would love to hear from you)
